Artisan Partners
TARA icon

Artisan Partners’s Protara Therapeutics TARA Stock Holding History

Artisan Partners’s Portfolio TARA Stock Details TARA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-379,946
Closed -$5.98M – 364
2021
Q1 		$5.98M Buy
379,946
+3,213
+0.9% +$59.6K 0.01% 328
2020
Q4 		$9.12M Buy
376,733
+80,349
+27% +$1.73M 0.01% 315
2020
Q3 		$4.99M Buy
+296,384
New +$6.87M 0.01% 312

Other funds holding TARA

OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Artisan Partners's TARA Position: Q2 2021 in Review

Artisan Partners sold out of Protara Therapeutics (TARA) in Q2 2021, closing a stake of 379,946 shares — an estimated $5.98M sold.

Artisan Partners first reported a position in TARA in Q3 2020 and held it in 3 quarters. The position peaked at $9.12M in Q4 2020. 41 funds tracked by Wall St. Rank hold TARA as of Q2 2021.

  • Artisan Partners reported no remaining Protara Therapeutics position as of Q2 2021 after selling out during the quarter.
  • Artisan Partners sold 379,946 Protara Therapeutics shares in Q2 2021, an estimated $5.98M.
  • Artisan Partners first reported a position in Protara Therapeutics in Q3 2020 and held it in 3 quarters.
  • Artisan Partners's Protara Therapeutics position peaked at $9.12M in Q4 2020.
  • 41 funds tracked by Wall St. Rank held Protara Therapeutics as of Q2 2021.

Based on Artisan Partners's 13F filing for Q2 2021, filed 12 Aug 2021.